Skip to content
411 PRESS
WarningRecall #D-0477-2026Drug / Pharmaceutical

SUN PHARMACEUTICAL INDUSTRIES INC Recalls Fluocinonide

SUN PHARMACEUTICAL INDUSTRIES INC · Class II — Moderate Risk

Assorted pharmaceutical pills and tablets — representative photo for FDA drug recall
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).

Product Description

Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3.

Reason for Recall

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

FDA Classification

Class II — Moderate Risk

A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Distribution

Nationwide in the USA.

Remedy

Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.

411 Press Analysis

SUN PHARMACEUTICAL INDUSTRIES INC has recalled a pharmaceutical product that the FDA classified as Class II affecting 2,640 60g tubes. The recall was initiated on March 25, 2026. Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.

Independent news on labor, safety, and accountability.